{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:04:49Z","timestamp":1771949089823,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H27-Gantaisaku-Ippan-005"],"award-info":[{"award-number":["H27-Gantaisaku-Ippan-005"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10147-018-1323-2","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T06:27:48Z","timestamp":1532932068000},"page":"1201-1211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current situation of cancer among adolescents and young adults in Japan"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-347X","authenticated-orcid":false,"given":"Akira","family":"Ohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Furui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Tatara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"1323_CR1","unstructured":"Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan. \n                    http:\/\/ganjoho.jp\/reg_stat\/index.html\n                    \n                  . (1st Sep 2017, date last accessed). (in Japanese)"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/jjco\/hyx070","volume":"47","author":"K Katanoda","year":"2017","unstructured":"Katanoda K, Shibata A, Matsuda T et al (2017) Childhood, adolescent and young adult cancer incidence in Japan in 2009\u20132011. Jpn J Clin Oncol 47:762\u2013771","journal-title":"Jpn J Clin Oncol"},{"key":"1323_CR3","unstructured":"The Health, Labor and Welfare Ministry of Japan (2017) Annual Population Statistics. \n                    http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/geppo\/nengai15\/index.html\n                    \n                  . (1st Sep 2017, date last accessed). (in Japanese)"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamapediatrics.2015.4689","volume":"170","author":"RD Barr","year":"2016","unstructured":"Barr RD, Ferrari A, Ries L et al (2016) Cancer in adolescents and young adults. A narrative review of the current status and a view of the future. JAMA Pediatr 170:495\u2013501","journal-title":"JAMA Pediatr"},{"key":"1323_CR5","unstructured":"Department of Health and Human Services, National Institutes of Health, National Cancer Institute, LIVESTRONG Young Adult Alliance (2006) Closing the gap: research and care imperatives for adolescents and young adults with cancer: a report of the Adolescent and Young Adult Oncology Progress Review Group. NIH Publication. \n                    https:\/\/www.cancer.gov\/types\/aya\/research\/ayao-august-2006.pdf\n                    \n                   (1st Sep 2017, date last accessed)"},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1200\/JCO.2010.30.5128","volume":"28","author":"DM Thomas","year":"2010","unstructured":"Thomas DM, Albritton KH, Ferrari A (2010) Adolescent and young adult oncology: an emerging field. J Clin Oncol 28:4781\u20134782","journal-title":"J Clin Oncol"},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1200\/JCO.2009.23.8097","volume":"28","author":"A Ferrari","year":"2010","unstructured":"Ferrari A, Thomas D, Franklin AR et al (2010) Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol 28:4850\u20134857","journal-title":"J Clin Oncol"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/pbc.21463","volume":"50","author":"R Barr","year":"2008","unstructured":"Barr R, Eden T (2008) International working group on adolescent\/teenage and young adult oncology. Pediatr Blood Cancer 50:1089","journal-title":"Pediatr Blood Cancer"},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.6004\/jnccn.2014.0138","volume":"12","author":"D Reed","year":"2014","unstructured":"Reed D, Block RG, Johnson R (2014) Creating an adolescent and young adult cancer program: lessons learned from pediatric and adult oncology practice bases. J Natl Compr Cancer Netw 12:1409\u20131415","journal-title":"J Natl Compr Cancer Netw"},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1016\/S1470-2045(14)70113-5","volume":"15","author":"LA Fern","year":"2014","unstructured":"Fern LA, Lewandowski JA, Coxon KM et al (2014) Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol 15:e341\u2013e350","journal-title":"Lancet Oncol"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.seminoncol.2009.03.003","volume":"36","author":"A Bleyer","year":"2009","unstructured":"Bleyer A, Barr R (2009) Cancer in young adults 20 to 39 years of age: overview. Semin Oncol 36:194\u2013206","journal-title":"Semin Oncol"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mpo.1257","volume":"38","author":"WA Bleyer","year":"2002","unstructured":"Bleyer WA (2002) Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival and importance of clinical trials. Med Pediatr Oncol 38:1\u201310","journal-title":"Med Pediatr Oncol"},{"key":"1323_CR13","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2009.22.2802","volume":"28","author":"P Butow","year":"2010","unstructured":"Butow P, Palmer S, Pai A et al (2010) Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol 28:4800\u20134809","journal-title":"J Clin Oncol"},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnci\/djr094","volume":"103","author":"JV Tricoli","year":"2011","unstructured":"Tricoli JV, Seibel NL, Blair DG et al (2011) Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst 103:628\u2013635","journal-title":"J Natl Cancer Inst"},{"key":"1323_CR15","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1200\/JCO.2010.28.3473","volume":"28","author":"GJ Veal","year":"2010","unstructured":"Veal GJ, Hartford CM, Stewart CF (2010) Clinical pharmacology in the adolescent oncology patient. J Clin Oncol 28:4790\u20134799","journal-title":"J Clin Oncol"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1200\/JCO.2010.30.5417","volume":"28","author":"B Zebrack","year":"2010","unstructured":"Zebrack B, Mathews-Bradshaw B, Siegel S (2010) Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol 28:4862\u20134867","journal-title":"J Clin Oncol"},{"key":"1323_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cncr.29866","volume":"122","author":"EL Warner","year":"2016","unstructured":"Warner EL, Kent EE, Trevino KM et al (2016) Social well-being among adolescents and young adults with cancer: a systematic review. Cancer 122:1029\u20131037","journal-title":"Cancer"},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","volume":"31","author":"AW Loren","year":"2013","unstructured":"Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500\u20132510","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1007\/s10147-018-1342-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000}}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1323-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1323-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1323-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T08:46:32Z","timestamp":1569314792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1323-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1323-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10147-018-1342-z","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"25 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication, Tables\u00a04 and 5 have not been published in a readable format. The corrected clear version is given in this Correction.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors except the following two report no conflict of interest: Kazuhito Yamamoto received honoraria from Kyowa Hakko Kirin, research funding from AbbVie, Celgene, Ono Pharmaceutical, ARIAD Pharmaceuticals, Novartis, Takeda, Eisai, Solasia Pharma, MSD, Chugai and Gilead Sciences. Chikako Shimizu received research funding from Chugai, MSD, and Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}